ATE301670T1 - Kappa rezeptor opioid peptide - Google Patents

Kappa rezeptor opioid peptide

Info

Publication number
ATE301670T1
ATE301670T1 AT98964224T AT98964224T ATE301670T1 AT E301670 T1 ATE301670 T1 AT E301670T1 AT 98964224 T AT98964224 T AT 98964224T AT 98964224 T AT98964224 T AT 98964224T AT E301670 T1 ATE301670 T1 AT E301670T1
Authority
AT
Austria
Prior art keywords
opioid peptides
kappa receptor
receptor opioid
kappa
peptides
Prior art date
Application number
AT98964224T
Other languages
English (en)
Inventor
Jean Louis Junien
Pierre J M Riviere
Claudio D Schteingart
Javier Sueiras Diaz
Jerzy A Trojnar
Todd W Vanderah
Original Assignee
Cara Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cara Therapeutics Inc filed Critical Cara Therapeutics Inc
Application granted granted Critical
Publication of ATE301670T1 publication Critical patent/ATE301670T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98964224T 1997-12-23 1998-12-22 Kappa rezeptor opioid peptide ATE301670T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides

Publications (1)

Publication Number Publication Date
ATE301670T1 true ATE301670T1 (de) 2005-08-15

Family

ID=25543752

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964224T ATE301670T1 (de) 1997-12-23 1998-12-22 Kappa rezeptor opioid peptide

Country Status (33)

Country Link
US (1) US5965701A (de)
EP (1) EP1042359B1 (de)
JP (1) JP4275852B2 (de)
KR (1) KR100629548B1 (de)
CN (1) CN1154655C (de)
AR (1) AR014167A1 (de)
AT (1) ATE301670T1 (de)
AU (1) AU747806B2 (de)
BR (2) BRPI9814499B8 (de)
CA (1) CA2315878C (de)
CR (1) CR5936A (de)
CZ (1) CZ297281B6 (de)
DE (1) DE69831176T2 (de)
DK (1) DK1042359T3 (de)
EE (1) EE04440B1 (de)
ES (1) ES2247735T3 (de)
HK (1) HK1029349A1 (de)
HR (1) HRP20000415B1 (de)
HU (1) HU227640B1 (de)
IL (3) IL136742A0 (de)
MY (1) MY117542A (de)
NO (1) NO327080B1 (de)
NZ (1) NZ505183A (de)
PL (1) PL195842B1 (de)
PT (1) PT1042359E (de)
RU (1) RU2217437C2 (de)
SK (1) SK286135B6 (de)
TR (1) TR200001985T2 (de)
TW (1) TW580502B (de)
UA (1) UA68366C2 (de)
UY (1) UY25327A1 (de)
WO (1) WO1999032510A1 (de)
ZA (1) ZA9811801B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
CN1283317C (zh) * 2001-05-08 2006-11-08 东丽株式会社 类鸦片κ受体激动性化合物在制备治疗败血症的药物中的应用
EP1894591B1 (de) 2002-03-20 2013-06-26 MannKind Corporation Kartusche für eine Inhalationsvorrichtung
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
KR101643478B1 (ko) 2005-09-14 2016-07-27 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US8217000B2 (en) * 2006-05-26 2012-07-10 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
EP2029617A2 (de) * 2006-05-26 2009-03-04 Cara Therapeutics, Inc. N-oxide von kappa-opioid-rezeptorpeptiden
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
BRPI0718651B8 (pt) * 2006-11-10 2021-05-25 Cara Therapeutics Inc amidas peptídicas sintéticas
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
CA2982550C (en) 2008-06-13 2020-08-25 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2300083T3 (da) 2008-06-20 2013-07-22 Mannkind Corp Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (es) 2009-03-11 2011-11-29 Mannkind Corp Aparato, sistema y metodo para medir la resistencia de un inhalador.
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
EP2872205B1 (de) 2012-07-12 2017-02-08 MannKind Corporation System zur verabreichung von arzneimitteln in trockenpulverform
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
ES2928365T3 (es) 2013-03-15 2022-11-17 Mannkind Corp Composiciones de dicetopiperazina microcristalina, métodos de preparación y uso del mismo
MX2020009878A (es) 2013-07-18 2022-07-27 Mannkind Corp Composiciones farmaceuticas en polvo seco estables al calor y metodos.
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
RU2664545C2 (ru) * 2014-06-26 2018-08-20 Маруиси Фармасьютикал Ко., Лтд. Способ получения синтетического пентапептида
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3294315A2 (de) * 2015-05-11 2018-03-21 Cadila Healthcare Limited Neuartige kurzkettige peptide als agonist des kappa-opiat-rezeptors (kor)
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
WO2018059331A1 (zh) 2016-09-27 2018-04-05 四川科伦博泰生物医药股份有限公司 多酰胺化合物及其用途
KR102375543B1 (ko) * 2017-07-21 2022-03-16 스촨 하이스코 파마수티컬 씨오., 엘티디 펩티드 아미드류 화합물 및 이의 제조 방법과 의약에서의 용도
CN111065631B (zh) 2017-12-06 2021-10-08 江苏恒瑞医药股份有限公司 一种苯基丙酰胺类衍生物的盐及其制备方法
CA3095966A1 (en) 2018-05-16 2019-11-21 Jiangsu Hengrui Medicine Co., Ltd. Pharmaceutical composition of kor receptor agonist
WO2021013086A1 (zh) * 2019-07-25 2021-01-28 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
CN114615976A (zh) * 2019-08-07 2022-06-10 人福医药美国公司 κ阿片受体肽酰胺激动剂
EP4175944A4 (de) 2020-06-25 2024-03-06 Humanwell Pharmaceutical US Peptide zur behandlung von medizinischen erkrankungen
TW202317533A (zh) 2021-07-02 2023-05-01 美商雅斯治療公司 奧沙奈坦(osanetant)之固體形式

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
HK1029349A1 (en) 2001-03-30
WO1999032510A1 (en) 1999-07-01
BRPI9814499B8 (pt) 2021-11-09
EE200000370A (et) 2001-10-15
EP1042359B1 (de) 2005-08-10
NO20003245D0 (no) 2000-06-21
IL178471A0 (en) 2007-02-11
UA68366C2 (en) 2004-08-16
NO327080B1 (no) 2009-04-20
IL136742A0 (en) 2001-06-14
BRPI9814499A (pt) 2000-10-10
HRP20000415B1 (en) 2004-06-30
KR100629548B1 (ko) 2006-09-27
ZA9811801B (en) 1999-06-22
EE04440B1 (et) 2005-02-15
HUP0100626A3 (en) 2001-12-28
UY25327A1 (es) 2000-12-29
MY117542A (en) 2004-07-31
AU747806B2 (en) 2002-05-23
CZ297281B6 (cs) 2006-10-11
HUP0100626A2 (hu) 2001-08-28
TW580502B (en) 2004-03-21
DE69831176T2 (de) 2006-04-20
IL136742A (en) 2006-12-31
CN1154655C (zh) 2004-06-23
BRPI9814499B1 (pt) 2014-10-21
BR9814499B1 (pt) 2014-10-21
BR9814499A (pt) 2000-10-10
PL341308A1 (en) 2001-04-09
SK9602000A3 (en) 2001-01-18
KR20010033450A (ko) 2001-04-25
CA2315878C (en) 2010-11-16
ES2247735T3 (es) 2006-03-01
CA2315878A1 (en) 1999-07-01
JP2001526295A (ja) 2001-12-18
AR014167A1 (es) 2001-02-07
HRP20000415A2 (en) 2000-12-31
NZ505183A (en) 2001-09-28
DE69831176D1 (de) 2005-09-15
JP4275852B2 (ja) 2009-06-10
RU2217437C2 (ru) 2003-11-27
HU227640B1 (en) 2011-10-28
TR200001985T2 (tr) 2000-11-21
EP1042359A1 (de) 2000-10-11
US5965701A (en) 1999-10-12
PT1042359E (pt) 2005-11-30
CZ20002382A3 (cs) 2000-12-13
SK286135B6 (sk) 2008-04-07
NO20003245L (no) 2000-08-23
AU1940299A (en) 1999-07-12
CR5936A (es) 2006-08-18
PL195842B1 (pl) 2007-10-31
CN1283201A (zh) 2001-02-07
WO1999032510A9 (en) 1999-09-23
DK1042359T3 (da) 2005-11-28

Similar Documents

Publication Publication Date Title
ATE301670T1 (de) Kappa rezeptor opioid peptide
IS4664A (is) Ný peptíð-ópíóíð
EP0977579A4 (de) Konjugate aus peptiden, die liganden von gastrinrezeptoren sind
NO982097L (no) Peptider
NO982098D0 (no) Peptider
ATE396204T1 (de) Peptide als antiangiogene arzneimittel
NO985680L (no) Peptidderivater
NO983849L (no) Peptidderivater
DE69617396D1 (de) T-Zellen beeinflussende Peptide
NO995299D0 (no) Kalsitonin reseptorbindende peptider
EE04001B1 (et) Peptiidne farmatseutiline kompositsioon
GB9718110D0 (en) Peptides
BR9606756A (pt) Peptídeo
GB9700154D0 (en) Peptides
NO981052D0 (no) Peptidderivater
FI965116A (fi) Uusia opioidipeptidiantagonisteja
NO981051D0 (no) Peptidderivater
ATE471944T1 (de) Antineoplastische peptide
EP1032586A4 (de) Hypusin enthaltende peptide
SI1042359T1 (sl) Kappa receptorski opioidni peptidi
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
GB9717431D0 (en) Peptide synthesis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042359

Country of ref document: EP